Procainamide Hydrochloride (Cardinal Health)


Welcome to the PulseAid listing for the Procainamide Hydrochloride drug offered from Cardinal Health. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: PROCAINAMIDE HYDROCHLORIDE
SUBSTANCE NAME: PROCAINAMIDE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1986-02-12
END MARKETING DATE: 0000-00-00


Procainamide Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProcainamide Hydrochloride from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/mL)
START MARKETING DATE: 1986-02-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-4740_a70a9886-743e-487c-883a-aaeebb62e0e8
PRODUCT NDC: 55154-4740
APPLICATION NUMBER: ANDA089070

Other PROCAINAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthProcainamide Hydrochloride
Hospira, Inc.Procainamide Hydrochloride
International Medication Systems, LimitedProcainamide Hydrochloride
McKesson Packaging Services Business Unit of McKesson CorporationProcainamide Hydrochloride
Nexus Pharmaceuticals IncProcainamide Hydrochloride